Treatment with GLP1-RA and GLP1-RA supplemented with GIP reduced body weight by 15% and 20% and decreased IR progression to DM [165], as the GLP1-RA liraglutide ameliorated IR and weight loss independently of GLP1-R signaling [166]. This evidence concerns the gene GCG and diabetes mellitus.